Clinical Trials Sponsored by BTG Ltd.

Total 17196 results

Leo Wang
BTS International

Completed

Clinical Study of Wrist Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard (WristBPM01)

Hypertension | Efficacy of Wrist BPM Measurement

China
West China Hospital
Tianjin Health Care Big Data Ltd.; Tianjin Health Commission

Completed

Hypertension Longitudinal Data Platform in Tianjin

Hypertension

China
Big Blue Biotech, Inc.

Terminated

A Study of the PedSCath Pediatric Sampling Catheter Versus Current Standard of Care.

Urinary Tract Infections in Children

United States
Leo Wang
BTS International

Completed

Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 (BPM_S)

Hypertension

China
Leo Wang
BTS International

Completed

Clinical Trail of Transtek Glass Body Fat Analyzer (GBFA)

Weight | Body Fat Disorder | Bone Mass

China
Big Bold Health, PBC
TruDiagnostic

Completed

The Impact of a Polyphenol-Rich Supplement on Epigenetic and Cellular Markers of Immune Age

Inflammation | Aging | Immunity Disorders

United States
University of Milan
BMG Pharma

Unknown

Effect of a Hydrogen-Peroxide and Hyaluronic-Acid Mouthwash (BMG0703) in the Treatment of Periodontitis

Periodontitis | Bleeding Gum | Pocket, Periodontal

Italy
University of Milan
BMG Pharma

Unknown

Evaluation of Hydrogen Peroxide and Hyaluronic Acid (BMG0703) in the Healing of Post-extraction Sites

Impacted Third Molar Tooth | Healing Surgical Wounds

Italy
OHSU Knight Cancer Institute
Oregon Health and Science University; BTG International Inc.

Recruiting

Glucarpidase After High-Dose Methotrexate in Patients With Osteosarcoma

Osteosarcoma

United States
Big Health Inc.
Boston University

Completed

Generalized Anxiety Therapy Effectiveness (GATE)

Generalized Anxiety Disorder

United States
Kaiser Permanente
Big Health Inc.

Completed

Trial of Internet-Based Cognitive Behavioral Therapy for Insomnia

Insomnia

United States
BTS International
West China Hospital

Completed

Clinical Study of Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard (BPM)

Hypertension

China
NC Heart and Vascular Research, LLC
Novate Medical Limited, a BTG Group Company

Completed

A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up

Recurrent Pulmonary Embolism (Disorder)

United States
Fundación Eduardo Anitua
BTI S.L

Active, not recruiting

Narrow Dental Implants in Multiple Fixed Prosthesis: A Controlled Clinical Trial

Edentulous Alveolar Ridge

Spain
University College Dublin
Irish Cancer Society; Big Health Ltd.; Research Electronic Data Capture (REDCap)

Not yet recruiting

The Sleepio After Cancer Study (SACS)

Cancer | Insomnia

Ireland
University of Oxford
Big Health Inc.

Active, not recruiting

Improving Sleep in Rehabilitation After Stroke (INSPIRES)

Stroke

United Kingdom
Imperial College London
Biocompatibles UK Ltd, a BT International group company

Recruiting

TheraSphere Selective Internal Radiation Therapy (SIRT) as Treatment for Neuroendocrine Tumours With Liver Mets (ArTisaN)

Neuroendocrine Tumors | Liver Metastases

United Kingdom
BG Unfallklinik

Unknown

Chitosan Nerv Tube for Primary Repair of Traumatic Sensory Nerve Lesions of the Hand (CNT)

Traumatic Lesion of Sensory Nerves of the Hand

Germany
BG Unfallklinik

Completed

Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections

Staphylococcal Infections

Germany
BG Unfallklinik

Completed

The Unstable Thoracic Cage Injury

Thoracic Spine Fracture | Concomitant Sternal Fracture
BG Unfallklinik

Unknown

Neurologic Complications in Peripheral Regional Anesthesia - An Evaluation Based on a Standardized Protocol

Adverse Effects | Nerve Block | Anesthesia, Conduction

Germany
University of Cambridge
Cambridgeshire and Peterborough NHS Foundation Trust; Cambridge Cognition Ltd; Big Health Inc...

Completed

CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis (CRISP)

Psychotic Disorders | Sleep | Psychosis

United Kingdom
University of Oxford
Big Health Inc.

Recruiting

Improving Sleep and Learning in Rehabilitation After Stroke, Part 2 (INSPIRES-2)

Stroke

United Kingdom
Universidad de Granada
BTI Biotechnology Institute

Active, not recruiting

Plasma Rich in Growth Factors in Post-extraction Sockets

Dental Implants | Tooth Extraction

Spain
Fundación Eduardo Anitua
BTI Biotechnology Institute

Completed

Clinical Evaluation of Polytetrafluoroethylene (PTFE, MATFILL) for the Sealing of Prosthetic Chimneys.

Edentulous Alveolar Ridge

Spain
Boehringer Ingelheim
Chengdu Big Data Association

Completed

Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database

Diabetes

China
Sherif Farag

Withdrawn

Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia

Aml | AML, Adult
Leo Wang
West China Hospital

Completed

Clinical Test for Transtek Glass Body Analyzer (GBA)

Weight | Body Fat Disorder | Bone Mass

China
TG Therapeutics, Inc.

Active, not recruiting

Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies

Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

Australia, Poland
TG Therapeutics, Inc.

Terminated

Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma

Follicular Lymphoma | Small Lymphocytic Lymphoma

United States
TG Therapeutics, Inc.

Terminated

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

B-cell Non Hodgkin Lymphoma | Richter's Transformation

United States
TG Therapeutics, Inc.

Terminated

Extension Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials

Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma

United States
TG Therapeutics, Inc.

Completed

Evaluate the Efficacy and Safety of TGR-1202 in Patients With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy

Chronic Lymphocytic Leukemia

United States
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 ) (ULTIMATE 1)

Relapsing Multiple Sclerosis (RMS)

United States
Nicholas Fidelman, MD
Merck Sharp & Dohme LLC; BTG International Inc.

Active, not recruiting

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

Neuroendocrine Neoplasm | Metastatic Malignant Neoplasm in the Liver

United States
David VanderWeele

Terminated

Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer (ADDItion)

Castrate Resistant Prostate Cancer

United States
Leo Wang
West China Hospital

Completed

Clinical Trial of Transtek Body Fat Analyzer (GBF-835-N2 & Other 7 Models) (15001Analy)

Weight | Body Fat Disorder

China
Leo Wang
West China Hospital

Completed

Clinical Trial of Transtek Body Fat Analyzer (GBF-1251-B & Other 3 Models) (BS-BT)

Weight | Body Fat Disorder | Bone Mass

China
Creighton University
BTR Group; Health Future Foundation

Completed

Relative Efficacy of Vitamins D2 and D3 in Adult Humans

Healthy

United States
TG Therapeutics, Inc.

Active, not recruiting

An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

Relapsing Multiple Sclerosis (RMS)

United States, Belarus, Croatia, Georgia, Poland, Russian Federation, Serbia, Ukraine
TG Therapeutics, Inc.

Terminated

Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V) (ULTRA-V)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Non Follicular Indolent Non-Hodgkin Lymphoma

United States
TG Therapeutics, Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304

Chronic Lymphocytic Leukemia

United States, Poland, Italy, United Kingdom
TG Therapeutics, Inc.

Completed

An Extension of the TG1101-RMS201 Trial

Relapsing Remitting Multiple Sclerosis

United States
TG Therapeutics, Inc.

Completed

Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) (GENUINE)

Chronic Lymphocytic Leukemia

United States, Israel
TG Therapeutics, Inc.

Terminated

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell Lymphomas

United States
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) (ULTIMATE II)

Relapsing Multiple Sclerosis (RMS)

United States
TG Therapeutics, Inc.

Completed

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia

United States
TG Therapeutics, Inc.

Completed

TGR-1202, a PI3K Delta Inhibitor, in Combination With Obinutuzumab and Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
TG Therapeutics, Inc.

Recruiting

A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk (PROVIDE)

Relapsing Multiple Sclerosis

United States

Clinical Trials Sponsored by BTG Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations